Kala Pharmaceuticals Inc. (KALA)
6.06
-0.26 (-4.11%)
At close: Mar 28, 2025, 3:59 PM
6.27
3.49%
After-hours: Mar 28, 2025, 07:50 PM EDT
Kala Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -0.4 | -260.14 | -0.52 | -3.17 | -1.24 | -1.96 | -3.02 | -9.64 | -19.16 | -23.1 | -41.97 |
| PEG Ratio | -0.00 | 2.60 | -0.06 | 0.11 | -0.06 | 0.03 | -0.01 | -0.1 | -0.93 | -0.28 | n/a |
| PS Ratio | n/a | 14.91 | 7.02 | 55.82 | 20.78 | n/a | n/a | n/a | 7.1K | 982.75 | 8.94K |
| PB Ratio | 2.27 | 3.06 | 4.70 | 3.55 | 4.25 | 1.25 | 1.42 | -3.64 | -5.64 | 137.08 | 2.21K |
| P/FCF Ratio | -0.6 | -0.73 | -0.72 | -3.83 | -1.34 | -2.35 | -3.69 | -11.62 | -20.83 | -28.69 | -38.44 |
| P/OCF Ratio | -0.61 | -0.74 | -0.73 | -3.92 | -1.36 | -2.42 | -3.74 | -11.69 | -21.18 | -29.11 | -41.24 |
| OCF/S Ratio | n/a | -20.27 | -9.63 | -14.26 | -15.27 | n/a | n/a | n/a | -335.31 | -33.76 | -216.84 |
| Debt / Equity Ratio | 4.84 | 2.26 | 4.77 | 1.01 | 3.41 | 0.95 | 0.21 | -0.11 | -0.17 | 1.43 | 23.14 |
| Quick Ratio | 6.33 | 3.05 | 3.09 | 7.48 | 4.07 | 10.17 | 7.97 | 8.23 | 1.38 | 3.65 | 1.07 |
| Current Ratio | 6.33 | 3.35 | 3.32 | 7.71 | 4.26 | 10.41 | 7.97 | 8.23 | 1.38 | 3.65 | 1.07 |
| Asset Turnover | n/a | 0.04 | 0.08 | 0.03 | 0.04 | n/a | n/a | n/a | 0.01 | 0.04 | 0.01 |
| Interest Coverage | -6.73 | -11.2 | -13.06 | -11.2 | -10.4 | -19.53 | -39.13 | -42.59 | -26.4 | -11.09 | -58.28 |
| Return on Equity (ROE) | -5.62 | -0.01 | -9.06 | -1.12 | -3.43 | -0.64 | -0.47 | 0.38 | 0.29 | -5.94 | -52.74 |
| Return on Assets (ROA) | -0.75 | -0.00 | -1.09 | -0.51 | -0.66 | -0.3 | -0.36 | -0.72 | -1.97 | -1.65 | -1.51 |
| Return on Capital (ROIC) | -0.82 | -1.33 | -1.07 | -0.48 | -0.68 | -0.32 | -0.39 | -0.8 | -5.42 | -2.03 | -7.48 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 34.22% | 63.55% | 50.13% | 66.94% | n/a | n/a | n/a | 100.00% | n/a | n/a |
| Net Profit Margin | n/a | -5.73% | -1.35K% | -1.76K% | -1.68K% | n/a | n/a | n/a | -37.07K% | -4.26K% | -21.31K% |
| Pretax Profit Margin | n/a | -1.15K% | -1.27K% | -1.64K% | -1.55K% | n/a | n/a | n/a | -37.07K% | -4.26K% | -21.31K% |
| Operating Profit Margin | n/a | -2.09K% | -973.6% | -1.51K% | -1.45K% | n/a | n/a | n/a | -35.44K% | -3.92K% | -22.26K% |
| FCF Margin | n/a | -2.04K% | -970.83% | -1.46K% | -1.55K% | n/a | n/a | n/a | -34.09K% | -3.43K% | -23.26K% |
| EBITDA Margin | n/a | -942.86% | -1.17K% | -1.46K% | -1.37K% | n/a | n/a | n/a | -35K% | -3.84K% | -20.52K% |